Cited by 218Alzheimer's disease research and treatmentsPluripotent Stem Cells ResearchNeurogenesis and neuroplasticity mechanisms

REST and neural gene network dysregulation in iPSC models of Alzheimer’s disease

Open access
Meyer, Katharina, Feldman, Heather M., Lu, Tao, Drake, Derek, Lim, Elaine T., Ling, King-Hwa, Bishop, Nicholas A., Pan, Ying +6 more·2019·Cell Reports

Abstract

The molecular basis of the earliest neuronal changes that lead to Alzheimer's disease (AD) is unclear. Here, we analyze neural cells derived from sporadic AD (SAD), APOE4 gene-edited and control induced pluripotent stem cells (iPSCs). We observe major differences in iPSC-derived neural progenitor (NP) cells and neurons in gene networks related to neuronal differentiation, neurogenesis, and synaptic transmission. The iPSC-derived neural cells from SAD patients exhibit accelerated neural differentiation and reduced progenitor cell renewal. Moreover, a similar phenotype appears in NP cells and cerebral organoids derived from APOE4 iPSCs. Impaired function of the transcriptional repressor REST is strongly implicated in the altered transcriptome and differentiation state. SAD and APOE4 expression result in reduced REST nuclear translocation and chromatin binding, and disruption of the nuclear lamina. Thus, dysregulation of neural gene networks may set in motion the pathologic cascade that leads to AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2019.01.023

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Three ApoE3 and ApoE4 isogenic iPSC pairs were used to determine the effect of APOE4 genotype without inter-donor variability.

    “Three ApoE3 and ApoE4 isogenic iPSCs pairs were used to determine the effect of APOE4 genotype without inter-donor variability.5”

    From ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes (2023) · cites this paper as [40]

    The Results section (‘APOE4 Induces Early Neuronal Differentiation and Dysregulation of REST’; page not provided) says the authors used isogenic iPSC lines differing only in APOE genotype to study its effects, which supports the rationale of avoiding inter-donor differences within a comparison. It describes editing lines from two donor backgrounds, not using three isogenic APOE3/APOE4 pairs. The three biological replicates reported in Methods are organoid samples, not three pairs. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Gene expression alteration of Pcdh-γC5 has been detected in the brain of Alzheimer's disease patients and animal models of Alzheimer's disease, as well as neural cells generated from human iPSCs that express APOE4.

    “The gene expression alteration of Pcdh-γC5 has also been detected in the brain of AD patients and animal models of AD, as well as neural cells generated from human iPSCs that express APOE4, a prevalent genetic AD risk factor (Nativio et al., 2018;Meyer et al., 2019).”

    From Cell Adhesion Molecule Protocadherin-γC5 Ameliorates Aβ Plaque Pathogenesis by Modulating Astrocyte Function in Alzheimer's Disease (2025) · cites this paper as Meyer et al., 2019

    The Results section on APOE4 and neuronal differentiation reports altered expression of other genes in APOE4 iPSC-derived neural progenitors and cerebral organoids. Our copy does not identify Pcdh-γC5 among them; searches for Pcdh-γC5, PCDHGC5, and protocadherin found no passage establishing the gene-specific claim. It also does not establish that alteration in AD patient or animal-model brains. (LLM, conf=0.80)

    Experimental — accuracy not yet measured
  • For studying age-related vulnerability and mechanisms relevant to AD, iNs have advantages over iPSC models and complement isogenic iPSC strategies.

    “Collectively, for studying age-related vulnerability and mechanisms relevant to AD, iNs have advantages over iPSC models and thus complement isogenic iPSC strategies (van der Kant et al., 2019; Meyer et al., 2019; Woodruff et al., 2013).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Meyer, K., Feldman, H. M., Lu, T., Drake, D., Lim, E. T., Ling, K.-H., Bishop, N. A., Pan, Y., Seo, J., Lin, Y.-T., Su, S. C., Church, G. M., Tsai, L.-H., & Yankner, B. A.
Affiliations
  • Harvard University (US)
  • Universiti Putra Malaysia (MY)
  • Massachusetts Institute of Technology (US)
Corresponding author
Yankner, Bruce A.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2019-01
Volume
26
Issue
5
Pages
1112-1127.e9
ISSN
2211-1247 (ISSN-L)
OpenAlex
W2913604250
Cited by
216
References
52
Citations by year
2026: 12 · 2025: 26 · 2024: 31 · 2023: 25 · 2022: 31 · 2021: 43 · 2020: 38 · 2019: 10
FWCI
21.09
Type
journal article
Language
en
Open access
Locations
  • Cell Reports (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia) (acceptedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion, other-oa)
  • PubMed Central (acceptedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
Funders
  • NIH (DP1OD006849, R01AG046174, RF1AG048056, RF1AG048029, RM1HG008525)
  • Paul F. Glenn Foundation for Medical Research
  • Fidelity Biosciences Research Initiative
  • Robert A. and Renee E. Belfer Family Foundation
  • Cure Alzheimer's Fund
  • DFG (ME 4810/1-1)
  • IBRO/ISN
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
Alzheimer's disease, rest, APOE ε4, induced pluripotent stem cells, iPSC-derived neural progenitor cells, iPSC-derived neurons, brain organoids, neuronal differentiation, neurogenesis, synaptic transmission, gene regulatory networks, nuclear lamina, sporadic Alzheimer's disease
MeSH terms
RE1-Silencing Transcription Factor, Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Cell Differentiation, Fibroblasts, Gene Expression Regulation, Humans, Middle Aged, Neurons, Repressor Proteins, Amyloid beta-Peptides, Nuclear Lamina, Gene Regulatory Networks, Neurogenesis, Induced Pluripotent Stem Cells, Neural Stem Cells, Cellular Reprogramming

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review